Similar Items: Repurposing the liquid-based Pap test for the detection of ovarian cancer protein biomarkers
- Protein modification systems as cancer biomarkers and therapeutic targets
- A Comparative Study to Predict Ovarian Cancer
- Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization
- Mass spectrometry‐based mitochondrial proteomics for cancer biomarker discovery
- Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer
- Exploring the impact of microbial dysbiosis on ovarian cancer and the therapeutic potential of probiotics